With its FDA approval for its OraSure HIV test in hand, Epitope Inc. now is rooting for Johnson & Johnson to expand the market by breaking open the home-based market for HIV tests.
EPT, which waited nearly three-and-a-half years after filing its PMA for the OraSure saliva sampling test kit, took orders for more than 1 million devices in the two business days last week following the FDA's approval, representing more than $2.8 million in revenue, said President and CEO Adolph Ferro.
The Beaverton, Ore., company hopes to begin distributing the devices to